# K014044: Mascular Computerized Psychophysical Test (MCPT)

- Pathway: 510(k) (Traditional)
- Applicant: Notal Vision, Inc.
- Decided: Mar 4, 2002 after 87 days
- Product code: HOQ (Grid, Amsler)
- Device class: 1
- Regulation: 21 CFR 886.1330
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
6 later devices descend from it; 1 cites it directly.
0 of 7 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names its predicate without a number.
- (no number) Amsler Grid: named in the summary without a submission number

## Most influential descendants
- K050350: The Notal Vision Preview Preferential Hyperacuity Perimeter (Preview PHP) (2005), 5 descendants of its own
- K091579: Foresee Home (2009), 4 descendants of its own
- K121738: Myvisiontrack (TM) (2013), 3 descendants of its own
- K143211: myVision Track Model 005 (2015), 2 descendants of its own
- K180895: Alleye (2018), 1 descendant of its own

## Indications for use
The Notal Vision Macular Computerized Psychophysical Test (MCPT) is indicated for the early detection of central and paracentral irregularities (visual abnormalities) in the visual field, most commonly associated with macular degeneration.

Source page: https://510kreport.com/device/K014044
Methodology: https://510kreport.com/methodology